Colposcopy is a diagnostic procedure, most commonly used in the diagnosis of cervical intraepithelial neoplasia and lower genital tract carcinoma. In this article, evidence-based management strategies are updated with discussion of the 2001 American Society for Colposcopy and Cervical Pathology Consensus Guidelines. Practice management issues include methods to improve cervical cancer screening...

Of the different strategies available for managing cervical intraepithelial neoplasia grade 1 (CIN1), testing for high-risk subtypes of the human papillomavirus (hr-HPV) DNA at 12 months has the highest sensitivity for predicting the development of CIN2 or CIN3 and leads to the lowest rate of referral to repeat colposcopy. If the hr-HPV DNA test result is negative at 12 months, then the patient...

Among the actions of early diagnosis of uterine cervix cancers, the sequence cytologic smear, colposcopy, cervix biopsy is well-known. The authors draw the attention that in some situations the cytologic smear and colposcopy are not sufficient and it is only biopsy that defines the nature of the lesion and may give therapeutic indications. Out of a series of 55 women to whom a cervix biopsy was...

Colposcopy is a technique used to examine the vagina [2] and cervix [3] to identify abnormalities or earlier stages of cervical cancer. During an exam, a physician uses an instrument, called a colposcope, that illuminates and magnifies the tissues. Hans Hinselmann developed the colposcope in December of 1924 in Hamburg, Germany. Hinselmann's colposcope enabled doctors to detect cervical tumors ...

Background: Invasive cervical cancer develops from a pre-invasive state named cervical intraepithelial neoplasia (CIN). CIN 1 represents mild dysplasia and is now classified as low-grade squamous intraepithelial lesion (LGSIL); CIN 2 and 3 lesions encompass moderate-to-severe dysplasia and are now classified as high-grade squamous intraepithelial lesions (HGSILs) based on the Bethesda cervical ...